Pharmaceutical companyLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field. in United StatesLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field., part of HQ Specialty PharmaLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field.. FDA records under its name, each linked to the record.
As of Nov 15, 2026, FDA's public records list HQ Specialty Pharma Corporation with 4 complete response letters. The most recent is a complete response letter dated Sep 14, 2021: Complete response letter, NDA 215212.
Drug approvals, 510(k) clearances, recalls and letters, 2017 to 2026 to date
A hatched bar is a year that is not over, so its count covers only part of the year.
| Sep 14, 2021 | Complete response letter, NDA 215212Approved | Complete response letters |
| Jan 8, 2021 | Complete response letter, NDA 211413Approved | Complete response letters |
| Dec 26, 2019 | Complete response letter, NDA 211413Approved | Complete response letters |
| Oct 19, 2018 | Complete response letter, NDA 211413Approved | Complete response letters |
Spellings are joined only when they reduce to the same name, or a reviewed source names the same company. Sharing an FDA establishment number (FEI) is not enough: contract sites make products for many firms. Facts marked AI were labelled by a language model from the firm's FDA names; everything else comes from FDA or Wikidata. How this page is built
